Table 2.
Treatment
n | % | |
---|---|---|
Surgery N = 42 |
|
|
Hysterectomy and bilateral salpingo-oophorectomy |
42 |
100% |
Lymphadenectomy |
|
|
Pelvic |
15 |
35.7% |
Pelvic and paraaortic |
17 |
40.5% |
None |
10 |
23.8% |
Adjuvant chomotherapy N = 42 |
|
|
Carboplatin/paclitaxel |
7 |
16.7% |
None |
35 |
83.3% |
Adjuvant radiotherapy N = 42 |
|
|
Intravaginal HDR brachytherapy alone |
5 |
11.9% |
Intravaginal HDR brachytherapy and external beam radiotherapy | 37 | 88.1% |